Drug Studies’ Results Make Case for Access to All Opioid Dependence Medications
Dr. Joseph Garbely, D.O., FASAM, Vice President of Medical Services and Medical Director, Caron Treatment Centers, is reassured by results of two recent studies, that showed comparable efficacy and safety between sublingual buprenorphine and injectable naltrexone for opioid dependence.
Healthy Digital Use or Dependence? The Facts May Surprise…
By Caron Staff